共 82 条
[1]
Kuenzli S(2003)Peroxisome proliferator-activated receptors in cutaneous biology Br J Dermatol 149 229-36
[2]
Saurat JH(2007)Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease Biochim Biophys Acta 1771 991-8
[3]
Michalik L(2006)Peroxisome proliferator-activated receptors increase human sebum production J Invest Dermatol 126 2002-9
[4]
Wahli W(2005)BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined immunodeficient mouse transplants after topical application J Pharmacol Exp Ther 315 996-1004
[5]
Trivedi NR(2005)Potential therapeutic role of peroxisome proliferator activated receptor-gamma agonists in psoriasis Expert Opin Pharmacother 6 1455-61
[6]
Cong Z(2006)Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease Expert Opin Investig Drugs 15 1453-68
[7]
Nelson AM(2004)PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis Carcinogenesis 25 1747-55
[8]
Albert AJ(2005)The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin Mol Carcinog 43 198-206
[9]
Rosamilia LL(2006)Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity Cancer Res 66 1873-8
[10]
Sivarajah S(2012)Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data Diabetologia 55 654-65